Membrane-associated farnesylated UCH-L1 promotes alpha-synuclein neurotoxicity and is a therapeutic target for Parkinson's disease.

Source:http://linkedlifedata.com/resource/pubmed/id/19261853

Proc. Natl. Acad. Sci. U.S.A. 2009 Mar 24 106 12 4635-40

Download in:

View as

Triples

General Info

PMID
19261853